Mov Disord Vol 35, Suppl 1 Archives - Page 119 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Anti-parkinson effect of natural L-DOPA containing drug Mucuna pruriens against the rotenone induced rat model of Parkinson’s disease
V. Kumar, F. Anwar (Allahabad, India)
Objective: The nanoherbaceutical formulation comprising natural L-DOPA from Mucuna pruriens against rotenone caused Parkinson's disease in rats to be prepared and evaluated. Background: Parkinson's disease…
MDS Virtual Congress 2020
Vascular age calculated by pulse wave velocity may help predict the prognosis after Deep brain stimulation surgery in patients with Parkinson’s disease
N. Naoko, K. Matsuura, A. Shindou, H. Kajikawa, T. Araki, H. Tomimoto (Tsu, mie, Japan)
Objective: We aimed to examine the relationship between pulse wave velocity (PWV) at pre- deep brain stimulation (DBS) stage and symptoms change at post-DBS stage.…
MDS Virtual Congress 2020
Low dose Cabergoline for freezing of gait in advanced Parkinson’s disease – you can have your cake and eat it too!
N. Sharma, A. Kumari, N. Sawal, H. Singh, K. Shukla (Chandigarh, India)
Objective: To evaluate efficacy of cabergoline for treating FOG in advanced IPD. Background: FOG is a major cause of disability in advanced IPD. FOG responds…
MDS Virtual Congress 2020
Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease
F. Wang, Y.T Zhang, S.Z Wei, C. Ren, C.F Liu (Suzhou, China)
Objective: We aimed to map the distribution of human neural stem cells (hNSCs) in the brain and peripheral tissues after intranasal administration in a mouse…
MDS Virtual Congress 2020
Disease stage and UMSARS progression: Implications for clinical trials
M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)
Objective: To study the rate of progression of multiple system atrophy (MSA) and assess for a potential ceiling effect of the Unified Multiple System Atrophy…
MDS Virtual Congress 2020
Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy
E. Bayram, J. Jankovic, S. Reich, C. Marras, Y. Bordelon, D. Shprecher, R. Dubinsky, I. Litvan (La Jolla, CA, USA)
Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…
MDS Virtual Congress 2020
Gait initiation in patients with Progressive Supranuclear Palsy: a biomechanical and FDG-PET study
M. Todisco, C. Palmisano, G. Marotta, C. Pacchetti, G. Pezzoli, I. Isaias (Würzburg, Germany)
Objective: To define the brain metabolic abnormalities related to gait initiation (GI) failure in subjects with Progressive Supranuclear Palsy (PSP). Background: PSP is an atypical…
MDS Virtual Congress 2020
Personal Kinetigraph and Deep Brain Stimulation with Parkinson’s Disease
A. Potter, G. Newsome, G. Kern, A. Parsons, D. Page, Y. Dalati, C. Sidiropoulos MD (East Lansing, MI, USA)
Objective: To better understand the utility of a wearable wrist sensor in assessing and managing motor fluctuations in a population of patients with advanced Parkinson…
MDS Virtual Congress 2020
Utility of VMAT2 inhibitors in management of stereotypy in children: a series of six patients
M. Hull, M. Parnes (Houston, TX, USA)
Objective: We aim to evaluate the effectiveness of VMAT2 inhibitors in the treatment of stereotypy. Background: Stereotypies are continual, rhythmic, patterned movements that can occur in typically-developing children, and are…
MDS Virtual Congress 2020
A Case of Lance Adams Syndrome with See-Saw Nystagmus
G. Keeton, T. Ali, P. Sudhakar, Z. Guduru (Lexington, KY, USA)
Objective: We present a case of Lance Adams syndrome (LAS) with see-saw nystagmus (SSN). LAS is a rare entity and first reported by Lance and Adams…